Intech Investment Management LLC Has $42.86 Million Position in Cardinal Health, Inc. $CAH

Intech Investment Management LLC lowered its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 21.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 208,541 shares of the company’s stock after selling 55,714 shares during the quarter. Intech Investment Management LLC’s holdings in Cardinal Health were worth $42,855,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of CAH. Vanguard Group Inc. raised its position in Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock valued at $6,461,179,000 after buying an additional 617,775 shares during the last quarter. Geode Capital Management LLC raised its position in Cardinal Health by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after buying an additional 43,924 shares during the last quarter. Wellington Management Group LLP raised its position in Cardinal Health by 153.2% in the 3rd quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Bank of America Corp DE raised its position in Cardinal Health by 3.2% in the 3rd quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock valued at $563,922,000 after buying an additional 111,582 shares during the last quarter. Finally, Invesco Ltd. raised its position in Cardinal Health by 14.7% in the 3rd quarter. Invesco Ltd. now owns 3,483,207 shares of the company’s stock valued at $546,724,000 after buying an additional 445,425 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.2%

CAH stock opened at $199.53 on Friday. The business has a 50 day moving average price of $203.82 and a two-hundred day moving average price of $208.88. The company has a market cap of $46.73 billion, a price-to-earnings ratio of 30.51, a P/E/G ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue was up 11.0% compared to the same quarter last year. During the same period last year, the company earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is presently 31.19%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CAH shares. Citigroup dropped their target price on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Morgan Stanley lifted their target price on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Leerink Partners reissued an “outperform” rating and issued a $275.00 target price on shares of Cardinal Health in a research report on Monday, March 9th. Barclays lifted their target price on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Finally, Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, May 2nd. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.